. 2023; 53(3): 175-182 | |||
Applications of Mitomycin C in Cornea and External DiseaseMarcos A. Crespo, Christopher J. Rapuano, Zeba A. SyedWills Eye HospitalIsolated from Streptomyces caespitosus, mitomycin C (MMC) has various applications in the management of cornea and external disease due to its ability to modulate cellular proliferation. It has been employed in pterygium surgery, ocular surface neoplasia, and refractive surgery. Currently, there is no definite consensus on the treatment protocols for each of the aforementioned applications. Although its benefits in the management of cornea and external disease are promising, MMC use has potential complications including endothelial cell loss, corneal perforation, scleral melt, secondary glaucoma, iritis, and endophthalmitis. This article will review the literature regarding the use of MMC in the field of cornea and external disease and describe protocols employed with corresponding outcomes. Keywords: Mitomycin C, MMC, Pterygium surgery, Photorefractive keratectomy scar, PRK hazeMarcos A. Crespo, Christopher J. Rapuano, Zeba A. Syed. Applications of Mitomycin C in Cornea and External Disease. . 2023; 53(3): 175-182 Corresponding Author: Zeba A. Syed, United States of America |
|